Schedule 13G ownership disclosure

CENTESSA PHARMACEUTICALS PLC

Ordinary shares, nominal value 0.002 GBP per share · CUSIP: 152309100

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Avoro Capital Advisors LLC

    Shares: 14,555,555.00 · Class: 9.97%

  • Behzad Aghazadeh

    Shares: 14,555,555.00 · Class: 9.97%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001025
Form type
SCHEDULE 13G/A
Filer
Avoro Capital Advisors LLC
CIK
CIK 1633313
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub